Monday, April 18 Integrated Neuroscience Session I6 1:00 p.m.–5:30 p.m. Integrated Neuroscience Session S Future Directions and Challenges in Stroke Team Action Therapy (STAT) This program is offered in partnership with the Stroke and Vascular Neurology Section. Coordinators: Jeffrey L. Saver, MD, FAAN, and Joseph P. Broderick, MD, FAAN Program Description: The INS program will present current uncertainties and future directions in acute stroke treatment. The introduction of mobile units with CT scan capability has the potential to reduce the delay in administration of i.v. thrombolysis by 45 minutes. New devices for mechanical thrombectomy are advancing this form of therapy and the program will present the diversity of new devices and their optimal therapeutic utilization. Advances in neuroimaging with rapid display of arterial thrombus location and extent of the penumbra region are extending the range of thrombolysis and improving the outcome of thrombectomy while pushing further out the frontiers of action. The recent development of comprehensive stroke centers with telestroke technology, mobile units, new neuroimaging capabilities, and increasingly sophisticated thrombectomy devices are reducing the time-delay for therapeutic action while paradoxically creating geographical disparities in access to care. A call to action is needed to reduce disparities. Upon Completion: Participants should be able to identify clinically relevant differences in phenotype or risk factors between males and females with neurological diseases. Part I 1:00 p.m.–3:00 p.m. 1:00 p.m.–1:10 p.m. Introduction Jeffrey L. Saver, MD, FAAN, and Joseph P. Broderick, MD, FAAN 1:10 p.m.–1:45 p.m. Invited Speaker The STAT Ambulance in Motion: Should My Center Get One? James C. Grotta, MD, FAAN, Houston, TX 1:45 p.m.–1:50 p.m. I6.001 Data Blitz Gaze Deviation and Acute Stroke Care Strategies —Zaid Mahdi, Anup Kumar Trikannad Ashwini Kumar, Pratik Bhattacharya, Ramesh Madhavan 1:50 p.m.–1:55 p.m. I6.002 Data Blitz Comparison of Large Vessel Occlusion Prediction Scores —Toby Gropen, Amelia Boehme, Sheryl Martin-Schild, Karen Albright, Brian Perrin, Alyana Samai, Sammy Pishanidar, Nazli Janjua, Steven Levine, Ethan Brandler, Dov Rosenbaum 1:55 p.m.–2:05 p.m. Audience Q&A 2:05 p.m.–2:40 p.m. Invited Speaker New Developments in Acute Stroke Neuroimaging: Future Directions Gregory W. Albers, MD, Stanford, CA 2:40 p.m.–2:45 p.m. I6.003 Data Blitz Variability in Approach to Treatment of Acute Central Retinal Artery Occlusion in US Teaching Hospitals —Matthew Schrag, Teddy Youn, Morgan Patrylo, Joseph Schindler, Patrick Lavin, Howard Kirshner, David Greer 2:45 p.m.–2:50 p.m. I6.004 Data Blitz Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence — Chandan Mehta, Mathew Jones, Mauricio Ruiz Cuero, Jody Wellwood, Mohammed Rehman, Panayiotis Mitsias, Panayiotis Varelas 2:50 p.m.–3:00 p.m. Audience Q&A Guided Poster Rounds I6.001 Gaze Deviation and Acute Stroke Care Strategies —Zaid Mahdi, Anup Kumar Trikannad Ashwini Kumar, Pratik Bhattacharya, Ramesh Madhavan I6.002 Comparison of Large Vessel Occlusion Prediction Scores —Toby Gropen, Amelia Boehme, Sheryl Martin- Schild, Karen Albright, Brian Perrin, Alyana Samai, Sammy Pishanidar, Nazli Janjua, Steven Levine, Ethan Brandler, Dov Rosenbaum I6.003 Variability in Approach to Treatment of Acute Central Retinal Artery Occlusion in US Teaching Hospitals — Matthew Schrag, Teddy Youn, Morgan Patrylo, Joseph Schindler, Patrick Lavin, Howard Kirshner, David Greer I6.004 Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence —Chandan Mehta, Mathew Jones, Mauricio Ruiz Cuero, Jody Wellwood, Mohammed Rehman, Panayiotis Mitsias, Panayiotis Varelas 3:00 p.m.–3:30 p.m. I6.005 Time is Brain: Standardized Neuro-Interventional Thrombectomy Protocols Lead to Faster Recanalization Times —Donald Frei, Lisa Caputo, Kathryn McCarthy, Kristin Salottolo, David Bar-Or I6.006 Effect of Annual Hospital Procedure Volume on Outcomes After Mechanical Thrombectomy in Acute Ischemic Stroke Patients: An Analysis of 13,502 Procedures —Achint Patel, Harshil Shah, Abhishek Lunagariya, Sanjeeva Onteddu, Sonal Mehta I6.007 Arterial Recanalization in the Golden Hour of IV TPA Administration for Ischemic Stroke —Rodica Bernatowicz, Megan Donohue, Muhammad Hussain, Seby John, Dolora Wisco, Ken Uchino I6.008 ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke —Andrew Barreto, Gary Ford, Loren Shen, Chunyan Cai, Claudia Pedroza, Jon Tyson, Mohammad Rahbar, James Grotta I6.009 Early CT Changes in Patients Admitted for Thrombectomy: Intra- and Interrater Agreement and Systematic Review of the Literature —Naim Khoury, Robert Fahed, Francois Guilbert, Alexandre Poppe, Nicole Daneault, Behzad Farazin, Andre Durocher, Sylvain Lanthier, Hayet Boudjani, Daniel Roy, Alain Weill, Jean- Christophe Gentric, Andre Lima Batista, Laurent Letourneau-Guillon, Francois Bergeron, Marc-Antoine Henry, Tim E. Darsaut, Jean Raymond I6.010 Onset to Reperfusion Times Strongly Determine Clinical Outcome Across a Wide Range of ASPECTS Scores in Endovascular Ischemic Stroke Therapy —Joon-Tae Kim, Mayank Goyal, Vitor Pereira-Mendes, Alain Bonafe, Jan Gralla, Reza Jahan, Elad Levy, David Liebeskind, Jeffrey Saver Part II I6.011 Overcoming Barriers to Reduce Door to Needle Times in Acute Ischemic Stroke Patients: Field to CT —Spozhmy Panezai, Florence Chukwuneke, Audrey Arango, Jaskiran Brar, Joshua Daniel, Daniel Korya, Siddhart Mehta, Mohammad Moussavi, Jawad Kirmani I6.012 Symptomatic Cerebral Ischemia Associated with Intensive Blood Pressure Lowering Following Acute Intracerebral Hemorrhage —Natalie Organek, Megan Donohue, Lauren Gotterer, Ken Uchino I6.013 The DRAGON Score Predicts Functional Outcomes in Acute Ischemic Stroke Patients Receiving Both Intravenous Tissue Plasminogen Activator (IVtPA) and Endovascular Therapy —Noorie Pednekar, Jin Li, Richard Zeman, Rachel Lehrer, Parvinder Kaur, Amrita Anreja, Emiliya Melkumova, Akira Todo, John Wainwright, Rivkah Epstein, Ramandeep Sahni, Stephen Marks, Michael Stiefel 3:30 p.m.–5:30 p.m. 3:30 p.m.–4:05 p.m. Invited Speaker Mechanical Thrombectomy Devices: How Many Are There and Where Are We Going? Johanna Fifi, MD, New York, NY 4:05 p.m.–4:10 p.m. I6.005 Data Blitz Time is Brain: Standardized Neuro-Interventional Thrombectomy Protocols Lead to Faster Recanalization Times —Donald Frei, Lisa Caputo, Kathryn McCarthy, Kristin Salottolo, David Bar-Or 4:10 p.m.–4:15 p.m. I6.006 Data Blitz Effect of Annual Hospital Procedure Volume on Outcomes After Mechanical Thrombectomy in Acute Ischemic Stroke Patients: An Analysis of 13,502 Procedures —Achint Patel, Harshil Shah, Abhishek Lunagariya, Sanjeeva Onteddu, Sonal Mehta 4:15 p.m.–4:25 p.m. Audience Q&A 4:25 p.m.–5:00 p.m. Invited Speaker Minimizing Geographical Disparities in Acute Stroke Treatment Dawn O. Kleindorfer, MD, Cincinnati, OH 5:00 p.m.–5:05 p.m. I6.007 Data Blitz Arterial Recanalization in the Golden Hour of IV TPA Administration for Ischemic Stroke —Rodica Bernatowicz, Megan Donohue, Muhammad Hussain, Seby John, Dolora Wisco, Ken Uchino 5:05 p.m.–5:10 p.m. I6.008 Data Blitz ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke —Andrew Barreto, Gary Ford, Loren Shen, Chunyan Cai, Claudia Pedroza, Jon Tyson, Mohammad Rahbar, James Grotta 5:10 p.m.–5:20 p.m. Audience Q&A 5:20 p.m.–5:30 p.m. Conclusion 82 2016 AAN Annual Meeting Abstract Listing
Meeting Schedule 1:00 p.m.–5:30 p.m. I6 S Future Directions and Challenges in Stroke Team Action Therapy (STAT) I7 The Human Connectome: Implications for Clinical Neurology . . . . . . . . . 84 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 C116 $ Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop (registration required) Director: Diego Torres-Russotto, MD, Omaha, NE 2:00 p.m.–3:00 p.m. Health & Wellness Mindfulness Meditation for Healthcare Practitioners Director: Sarah Mulukutla, MD, MPH, Stamford, CT 3:00 p.m.–4:00 p.m. Health & Wellness “Physical Exercise and Cognitive Training in Neurology”—Exercise in Stroke Director: AM Barrett, MD, West Orange, NJ 3:30 p.m.–4:30 p.m. I The Future of Payment Director: Lyell K. Jones, MD, FAAN, Rochester, MN 3:30 p.m.–5:30 p.m. S24: Clinical Outcomes and Treatment Strategies in Multiple Sclerosis . . . . . . . . 86 S25: Movement Disorders: Huntington’s Disease . . . . . . . . . . . . . . . . . . 86 S26: Headache. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 C117 Clinical Approach to Muscle Disease II Director: Andrew Mammen, MD, PhD, Baltimore, MD C118 Therapy in Neurology II Director: David W. Dodick, MD, Phoenix, AZ C119 Common Spine Disorders II: Treatment Director: J. D. Bartleson, MD, FAAN, Rochester, MN C120 Cerebrovascular Disease III: Acute Ischemic Stroke Director: Philip B. Gorelick, MD, MPH, FAAN, Grand Rapids, MI C121 Emotional Communication: Chalk Talk Director: Kenneth M. Heilman, MD, FAAN, Gainesville, FL C122 Nonmotor Manifestations of Parkinson’s Disease II Director: Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ C123 Status Epilepticus Director: Frank W. Drislane, MD, FAAN, Newton, MA C124 Core Concepts in Pain Management II: Safe Opioid Prescribing ? Practical Considerations, Unintended Consequences, and Legal Issues Director: James C. Watson, MD, Rochester, MN C125 Sleep for the Practicing Neurologist II: Sleep Duration, CNS Hypersomnias, and Treating Physician Fatigue Director: Michael J. Howell, MD, FAAN, Minneapolis, MN C126 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II (registration required) Director: Gary S. Gronseth, MD, FAAN, Kansas City, KS 4:00 p.m.–5:00 p.m. Health & Wellness Introduction to Stress Mastery—Going Beyond Stress Management Director: Ravinder Singh, MD, Beverly Hills, CA 4:30 p.m.–6:30 p.m. Exhibit Hall Opening Reception $ A registration fee is required L The program is one of the AAN Leadership University sessions S The course is part of a Subspecialty in Focus track I The program is one of the I Talk sessions Learning Lab The program is part of the Excitement of Discovery Experiential Learning Area Health & Wellness sessions Real World of Neurology Mon · April 18 Fast and easy registration · AAN.com/view/AM16 83
Change language